Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversité Catholique de Louvain

About this trial

Identify rare variants in candidate genes and pathways identified in familial SSc, in patients with sporadic SSc.

Perform (spatial) transcriptomic and proteomic analyses of affected skin from patients with and without cutaneous fibrosis, for the patterns and levels of expression/activation of candidate genes and pathways.

Test for dysregulation of expression/activation of candidate genes and pathways in live cells isolated from the blood and skin biopsy of patients, and for the impact of these dysregulations on cell appearance, behavior and function.

Eligibility criteria

Qualifiers

Limited SSc

Limited cutaneous SSc

Diffuse cutaneous SSc

Patients followed regularly in consultations at CUSL.

Disqualifiers

Other (co-occurring) autoimmune/autoinflammatory disease

Pregnancy

Participants with temporary or definitive disabilities to give consent

Participants unable to sign or read the inform consent form

Trial design

Treatments tested in this trial

  • cutaneous biospy

Treatment groups

15 Participants
are divided into 1 treatment group

Locations

This trial has no locations